Healthcare Services

Gastrointestinal Stromal Tumor Market Revenue Expected to Reach $1.98 Billion by 2030 with 8% CAGR

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Gastrointestinal Stromal Tumor Market In 2026 And What Value Is Projected For 2030?

The gastrointestinal stromal tumor market size has seen strong expansion in recent years. It is forecast to increase from $1.36 billion in 2025 to $1.46 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.9%. The historical period’s growth was driven by the approval of imatinib therapy, improved tumor classification, the expansion of oncology care centers, increased awareness of rare gi tumors, and the availability of surgical interventions.

The market for gastrointestinal stromal tumors is anticipated to experience robust expansion in the coming years. This market is projected to reach $1.98 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this growth during the forecast period include the advancement of next-generation targeted treatments, the rise of precision diagnostics, an increase in clinical research, the broadening of personalized cancer care, and enhanced patient survival rates. Key trends anticipated in the upcoming period encompass the escalating adoption of targeted tyrosine kinase inhibitors, a heightened emphasis on molecular tumor characterization, the broadening scope of precision oncology strategies, an increase in combined surgical and drug therapies, and better long-term disease management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13248&type=smp

What Key Drivers Are Influencing The Growth Of The Gastrointestinal Stromal Tumor Market?

An increasing number of stomach cancer cases is projected to propel the expansion of the gastrointestinal stromal tumor market in the future. Stomach cancer is characterized by the uncontrolled proliferation of malignant cells within the stomach’s lining. While gastrointestinal stromal tumors (GISTs) can develop in the stomach, they are distinct from stomach cancer. It has been observed that when two separate tumors collide and merge into one, patients with GISTs have an elevated risk of developing additional cancers, such as small bowel adenocarcinoma. For instance, in January 2024, the American Cancer Society, a US-based professional organization, estimated about 26,890 new cases of stomach cancer and 10,880 deaths in the U.S. for 2024, making up 1.5% of all new cancer diagnoses. Thus, the rising incidence of stomach cancer is serving as a catalyst for the growth of the gastrointestinal stromal tumor market.

What Are The Key Segments Of The Gastrointestinal Stromal Tumor Market?

The gastrointestinal stromal tumor market covered in this report is segmented –

1) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types

2) By Indication: Stomach, Small Intestine, Others Indications

3) By End-User: Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy Regimens

2) By Targeted Therapy: Tyrosine Kinase Inhibitors, Other Targeted Agents

3) By Other Treatment Types: Surgery, Radiation Therapy, Clinical Trials For Novel Therapies

What Key Developments And Trends Are Impacting The Gastrointestinal Stromal Tumor Market?

Leading companies in the gastrointestinal stromal tumor market are introducing innovative drugs, such as signal transduction and targeted therapy, aiming to improve treatment efficacy, address resistance to existing therapies, and fulfill unmet clinical needs. Signal transduction and targeted therapy are treatments specifically formulated to block or modify cellular signaling pathways that drive tumor proliferation and survival. For example, in November 2025, Ascentage Pharma Group International Inc., a China-based commercial-stage biopharmaceutical company, revealed the publication of Phase Ib clinical data for olverembatinib (HQP1351) in Signal Transduction and Targeted Therapy, which demonstrated encouraging efficacy and safety in SDH-deficient gastrointestinal stromal tumors (GIST) and identified a novel antitumor mechanism involving lipid metabolism modulation.

Who Are The Leading Companies Operating In The Gastrointestinal Stromal Tumor Market?

Major companies operating in the gastrointestinal stromal tumor market are Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck & Co. Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., NATCO Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd.

Read the full gastrointestinal stromal tumor market report here:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-stromal-tumor-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Gastrointestinal Stromal Tumor Market?

North America was the largest region in the gastrointestinal stromal tumor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gastrointestinal Stromal Tumor Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13248&type=smp

Browse Through More Reports Similar to the Global Gastrointestinal Stromal Tumor Market 2026, By The Business Research Company

Food Pathogen Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/food-pathogen-testing-global-market-report

Infectious Disease Diagnostics Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Food Pathogen Safety Testing Equipment And Supplies Global Market Report

https://www.thebusinessresearchcompany.com/report/food-pathogen-safety-testing-equipment-and-supplies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795